Outside the usual rangeMay 2021Maternal and child
Mizoram: MCV1 doses per 100 BCG doses in May 2021 was 119.5 per 100 BCG doses, above the 4-year median of 95.7 for the same month (+25%).
What happened
- May 2021
- 119.5
- 4-year median
- 95.7
- Change
- +23.8
- Change, per cent
- +25%
Why it matters
The value is judged against the median of the same period in up to five earlier years, using a robust measure of spread. A breach means this period sits well outside what those years would lead you to expect.
For MCV1 doses per 100 BCG doses, higher is better. This movement is therefore assessed as an improvement.
Historical context
Same-period values: 2020 99.5, 2019 96.1, 2018 11.9, 2017 95.4. This comparison involves the COVID-19 disruption period (March 2020 – June 2021), when service use and reporting fell sharply.
The underlying data
| Period | Value | Release | Where in the document |
|---|---|---|---|
| May 2021 | 119.5 | HMIS item-wise monthly report, All India across states, May 2021 (FY 2021-22, provisional) | 2021-2022(Data is Provisional)/A.MonthWise/B-May.xlsx: ('9.2.1' Child immunisation (9-11months) - Measles & Rubella (MR)/ Measles containing vaccine(MCV) - 1st Dose + '9.2.2' Child immunisation (9-11months) - Measles 1st dose) / ('9.1.2' Child immunisation - BCG) × 100; column "Mizoram", Total [(A+B) or (C+D)] |
| May 2020 | 99.5 | HMIS item-wise monthly report, All India across states, May 2020 (FY 2020-21, provisional) | 2020-2021(Data is Provisional)/A.MonthWise/B-May.xlsx: ('9.2.1' Child immunisation (9-11months) - Measles & Rubella (MR)/ Measles containing vaccine(MCV) - 1st Dose + '9.2.2' Child immunisation (9-11months) - Measles 1st dose) / ('9.1.2' Child immunisation - BCG) × 100; column "Mizoram", Total [(A+B) or (C+D)] |
| May 2019 | 96.1 | HMIS item-wise monthly report, All India across states, May 2019 (FY 2019-20, provisional) | 2019-2020.zip › 2019-2020/A.MonthWise/B - May.xls: ('9.2.1' Child immunisation (9-11months) - Measles & Rubella (MR)- 1st Dose + '9.2.2' Child immunisation (9-11months) - Measles 1st dose) / ('9.1.2' Child immunisation - BCG) × 100; column "Mizoram", Total [(A+B) or (C+D)] |
| May 2018 | 11.9 | HMIS item-wise monthly report, All India across states, May 2018 (FY 2018-19, provisional) | 2018-2019.zip › 2018-2019/A.MonthWise/B - May.xls: ('9.2.1' Child immunisation (9-11months) - Measles & Rubella (MR)- 1st Dose + '9.2.2' Child immunisation (9-11months) - Measles 1st dose) / ('9.1.2' Child immunisation - BCG) × 100; column "Mizoram", Total [(A+B) or (C+D)] |
Source and method
More signals for MCV1 doses per 100 BCG doses in Mizoram
- Mizoram: MCV1 doses per 100 BCG doses of 119.5 per 100 BCG doses in May 2021 is the highest since March 2020.
- Mizoram: MCV1 doses per 100 BCG doses in February 2021 was 112.3 per 100 BCG doses, above the 3-year median of 86.1 for the same month (+30%).
- Mizoram: MCV1 doses per 100 BCG doses rose to 112.3 per 100 BCG doses in February 2021, against 86.1 a year earlier (+30%).
- Mizoram: MCV1 doses per 100 BCG doses in April 2020 was 110.9 per 100 BCG doses, above the 3-year median of 80.0 for the same month (+39%).
- Mizoram: MCV1 doses per 100 BCG doses rose to 110.9 per 100 BCG doses in April 2020, against 81.3 a year earlier (+36%).
- Mizoram: MCV1 doses per 100 BCG doses of 125.1 per 100 BCG doses in March 2020 is the highest in the series, which begins April 2017.
Cite this
According to the India Health Observatory, Mizoram: MCV1 doses per 100 BCG doses in May 2021 was 119.5 per 100 BCG doses, above the 4-year median of 95.7 for the same month (+25%). Source: Health Management Information System, Ministry of Health and Family Welfare, HMIS item-wise monthly report, All India across states, May 2021 (FY 2021-22, provisional). https://indiahealthobservatory.com/signals/mcv1-to-bcg-ratio--mizoram--2021-05--baseline_breach
See also Mizoram and 119.5 per 100 BCG doses in context.